drugset / Trial / NCT06204107
A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, open-label, single dose, crossover, phase Ⅰ trial to evaluate the food effect on pharmacokinetic profiles and safety of CKD-379 in healthy volunteers
Timeline
- Start
- 2023-11-21
- Primary completion
- 2023-12-06
- Completion
- 2023-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |
| Subject | Sitagliptin | Small molecule | — | Oral |